Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-24-002137
Filing Date
2024-11-14
Accepted
2024-11-14 14:30:03
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 10-Q SEC FILING tpia-20240930.htm   iXBRL 10-Q 566364
2 CERTIFICATION tpia_ex31.htm EX-31 8444
3 CERTIFICATION tpia_ex32.htm EX-32 4357
  Complete submission text file 0001096906-24-002137.txt   2864770

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20240930_cal.xml EX-101.CAL 18523
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20240930_def.xml EX-101.DEF 82193
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20240930_lab.xml EX-101.LAB 144368
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20240930_pre.xml EX-101.PRE 145070
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20240930.xsd EX-101.SCH 35099
68 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20240930_htm.xml XML 385971
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56022 | Film No.: 241460442
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)